Hepatitis C virus RNA quantitation in venous and capillary small-volume whole-blood samples

Journal of Clinical Microbiology

Volumn 47, Issue 10, 2009, Pages 3231-3240

  Bruns, Tony ^a,b,c   Steinmetzer, Katrin ^b   Ermantraut, Eugen ^b   Stallmach, Andreas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b CLONDIAG GmbH   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACCURACY; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CAPILLARY BLOOD; CONTROLLED STUDY; EXTRACTION; GENOTYPE; HEMATOCRIT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VENOUS BLOOD; VIRUS LOAD;

BLOOD; CAPILLARIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 70349650318     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00925-09     Document Type: Article

References (43)

1. Bartolomé, J., J. M. López-Alcorocho, I. Castillo, E. Rodríguez-Iñigo, J. A. Quiroga, R. Palacios, and V. Carreño. 2007. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J. Virol. 81:7710-7715. (Pubitemid 47047856)
2. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310. (Pubitemid 16134762)
3. Bouffard, P., P. H. Hayashi, R. Acevedo, N. Levy, and J. B. Zeldis. 1992. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J. Infect. Dis. 166:1276-1280.
4. Carreño, V., I. Castillo, J. Bartolomé, E. Rodríguez-Iñigo, N. Ortiz-Movilla, S. de Lucas, and M. Pardo. 2004. Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. J. Clin. Virol. 31:312-313.
5. Castillo, I., M. Pardo, J. Bartolomé, N. Ortiz-Movilla, E. Rodríguez-Iñigo, S. de Lucas, C. Salas, J. A. Jiménez- Heffernan, A. Pérez-Mota, J. Graus, J. M. López-Alcorocho, and V. Carreño. 2004. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J. Infect. Dis. 189:7-14.
6. Chen, G., L. Kobayashi, and I. Nazarenko. 2007. Effect of sample aliquot size on the limit of detection and reproducibility of clinical assays. Clin. Chem. 53:1962-1965.
7. Chevaliez, S., M. Bouvier-Alias, R. Brillet, and J. Pawlotsky. 2007. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 46:22-31. (Pubitemid 47171917)
8. Cook, L., A. M. Ross, G. B. Knight, and V. Agnello. 2000. Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity. J. Clin. Microbiol. 38:4326-4331.
9. Cotten, M., B. Oberhauser, H. Brunar, A. Holzner, G. Issakides, C. R. Noe, G. Schaffner, E. Wagner, and M. L. Birnstiel. 1991. 2′-O-methyl, 2′-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event. Nucleic Acids Res. 19:2629-2635. (Pubitemid 21896898)
10. Daniel, H. D. J., J. David, P. R. Grant, J. A. Garson, G. M. Chandy, and P. Abraham. 2008. Whole blood as an alternative to plasma for detection of hepatitis C virus RNA. J. Clin. Microbiol. 46:3791-3794.
11. Fytili, P., C. Tiemann, C. Wang, S. Schulz, S. Schaffer, M. P. Manns, and H. Wedemeyer. 2007. Frequency of very low HCV viremia detected a highly sensitive HCV-RNA assay. J. Clin. Virol. 39:308-311.
12. Gleaves, C. A., J. Welle, M. Campbell, T. Elbeik, V. Ng, P. E. Taylor, K. Kuramoto, S. Aceituno, E. Lewalski, B. Joppa, L. Sawyer, C. Schaper, D. McNairn, and T. Quinn. 2002. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 30 assay: analytical and clinical performance. J. Clin. Virol. 25:205-216.
13. Hakim, H., C. Gibson, J. Pan, K. Srivastava, Z. Gu, M. J. Bankowski, and R. T. Hayden. 2007. Comparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral blood. J. Clin. Microbiol. 45:2151-2155.
14. Hamaia, S., C. Li, and J. P. Allain. 2001. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 98:2293-2300.
15. Hess, C., T. Klimkait, L. Schlapbach, V. D. Zenero, S. Sadallah, E. Horakova, G. Balestra, V. Werder, C. Schaefer, M. Battegay, and J. Schifferli. 2002. Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study. Lancet 359:2230-2234. (Pubitemid 34717976)
16. + RNA from 4 M guanidine thiocyanate-lysed cell extracts using locked nucleic acid-oligo( T) capture. Nucleic Acids Res. 32:e64.
17. Kuiken, C., K. Yusim, L. Boykin, and R. Richardson. 2005. The Los Alamos hepatitis C sequence database. Bioinformatics 21:379-384. (Pubitemid 40246609)
18. Kumar, R., S. K. Singh, A. A. Koshkin, V. K. Rajwanshi, M. Meldgaard, and J. Wengel. 1998. The first analogues of LNA (locked nucleic acids): phosphorothioate- LNA and 2′-thio-LNA. Bioorg. Med. Chem. Lett. 8:2219-2222.
19. Lavanchy, D. 2009. The global burden of hepatitis C. Liver Int. 29(Suppl.):174-181.
20. Limpert, E., W. A. Stahel, and M. Abbt. 2001. Log-normal distributions across the sciences: keys and clues. BioScience 51:341-352. (Pubitemid 32550418)
21. Lotz, G., F. Szalay, G. Firneisz, M. Abonyi, G. Lengyel, L. Telegdy, E. Ibrányi, B. Nemes, F. Kury, Z. Schaff, and S. Simon. 2002. Localization of hepatitis C virus RNA on human erythrocytes RT in situ PCR technique. Scand. J. Gastroenterol. 37:578-584.
22. Manzin, A., L. Solforosi, M. Candela, G. Cherubini, G. Piccinini, M. Brugia, A. Gabrielli, and M. Clementi. 1996. Hepatitis C virus infection and mixed cryoglobulinaemia: assessment of HCV RNA copy numbers in supernatant, cryoprecipitate and non-liver cells. J. Viral. Hepat. 3:285-292.
23. Meier, V., S. Mihm, P. B. Wietzke, and G. Ramadori. 2001. HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication? World J. Gastroenterol. 7:228-234. (Pubitemid 32377475)
24. Moldvay, J., P. Deny, S. Pol, C. Brechot, and E. Lamas. 1994. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients in situ hybridization. Blood 83:269-273. (Pubitemid 24016541)
25. Muratori, L., D. Gibellini, M. Lenzi, M. Cataleta, P. Muratori, M. C. Morelli, and F. B. Bianchi. 1996. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 88:2768-2774. (Pubitemid 26327532)
26. National Institutes of Health. 2002. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens. State. Sci. Statements 19:1-46.
27. Nishiguchi, S., K. Fukuda, S. Shiomi, T. Takeda, T. Kuroki, M. Ogami, H. Morimoto, S. Otani, M. Sakurai, and A. Matsuhisa. 2003. Peripheral blood mononuclear cells are possible extrahepatic replication sites for hepatitis C virus. Hepatogastroenterology 50:1301-1304. (Pubitemid 37186469)
28. Passing, H., and W. Bablok. 1983. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. J. Clin. Chem. Clin. Biochem. 21:709-720.
29. Pugnale, P., E. Herrmann, A. U. Neumann, J. Pawlotsky, S. W. Schalm, C. Ferrari, Y. Homburger, S. Zeuzem, F. Negro, and DITTO-HCV Study Group. 2008. Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy. J. Hepatol. 48:932-938.
30. Radkowski, M., J. F. Gallegos-Orozco, J. Jablonska, T. V. Colby, B. Walewska-Zielecka, J. Kubicka, J. Wilkinson, D. Adair, J. Rakela, and T. Laskus. 2005. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114. (Pubitemid 40066388)
31. Roque-Afonso, A. M., J. Jiang, F. Penin, C. Tareau, D. Samuel, M. A. Petit, H. Bismuth, E. Dussaix, and C. Féray. 1999. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J. Virol. 73:9213-9221. (Pubitemid 29487076)
32. Sadallah, S., M. Heim, C. Hess, T. Klimkait, M. Battegay, and J. A. Schifferli. 2005. Contrary to HIV, hepatitis C virus is not associated with erythrocytes in vivo. J. Hepatol. 42:150-152. (Pubitemid 40038917)
33. Saldanha, J., N. Lelie, A. Heath, and WHO Collaborative Study Group. 1999. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang. 76:149-158.
34. Sarrazin, C., B. C. Gärtner, D. Sizmann, R. Babiel, U. Mihm, W. P. Hofmann, M. von Wagner, and S. Zeuzem. 2006. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J. Clin. Microbiol. 44:729-737.
35. Schmidt, W. N., P. Wu, J. Q. Han, M. J. Perino, D. R. LaBrecque, and J. T. Stapleton. 1997. Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J. Infect. Dis. 176:20-26.
36. Sizmann, D., C. Boeck, J. Boelter, D. Fischer, M. Miethke, S. Nicolaus, M. Zadak, and R. Babiel. 2007. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J. Clin. Virol. 38:326-333.
37. Stapleton, J. T., D. Klinzman, W. N. Schmidt, M. A. Pfaller, P. Wu, D. R. LaBrecque, J. Han, M. J. Phillips, R. Woolson, and B. Alden. 1999. Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J. Clin. Microbiol. 37:484-489.
38. Watkins-Riedel, T., P. Ferenci, P. Steindl-Munda, M. Gschwantler, C. Mueller, and M. Woegerbauer. 2004. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy means of HCV RNA whole-blood analysis. Clin. Infect. Dis. 39:1754-1760.
39. Xu, D., Y. Xie, and Z. Li. 2005. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C. Hepatobiliary Pancreat. Dis. Int. 4:550-553.
40. Yanagi, M., R. H. Purcell, S. U. Emerson, and J. Bukh. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA 94:8738-8743.
41. Zahn, A., N. Jennings, W. H. Ouwehand, and J. Allain. 2006. Hepatitis C virus interacts with human platelet glycoprotein VI. J. Gen. Virol. 87:2243-2251.
42. Zehender, G., L. Meroni, C. D. Maddalena, S. Varchetta, G. Monti, and M. Galli. 1997. Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J. Infect. Dis. 176:1209-1214.
43. Zignego, A. L., C. Giannini, M. Monti, and L. Gragnani. 2007. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig. Liver. Dis. 39(Suppl.):S38-S45.